ASCO GU: No Help from Continuous Tx in Metastatic RCC - MedPage Today PDF Print
MedPage Today
ORLANDO -- Outcomes in metastatic renal cell carcinoma did not improve with continuous dosing of sunitinib (Sutent) compared with the conventional 4/2 dosing regimen, results of a multicenter randomized

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.